| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |